Bioventus has been granted a patent for an apparatus that can power implantable devices within the body. The device includes a power adapter that receives energy transcutaneously, converts it, and transfers it to the implantable device to power it. GlobalData’s report on Bioventus gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Bioventus Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Bioventus, was a key innovation area identified from patents. Bioventus's grant share as of February 2024 was 56%. Grant share is based on the ratio of number of grants to total number of patents.

Implantable device powered by transcutaneous energy transfer

Source: United States Patent and Trademark Office (USPTO). Credit: Bioventus Inc

A recently granted patent (Publication Number: US11890485B2) outlines a method for transferring energy from an electrical pulse generator to an implantable device within the body. The method involves receiving energy transcutaneously at a power adapter, converting it to a different form via a rectification circuit, and transferring it to the implantable device to stimulate a target nerve internally. The energy conversion process includes adjusting characteristics such as frequency and waveform to optimize the stimulation process.

Furthermore, the patent details various scenarios where the energy received includes a combination of low and high-frequency bursts, with the method designed to ensure the high-frequency bursts are converted and transferred effectively for nerve stimulation. The rectification circuit within the power adapter plays a crucial role in this process, with components like rectifying diodes, capacitors, and resistors working together to facilitate the energy transfer. Additionally, measures such as shorting the rectifying diode at specific frequencies and incorporating a Zener diode for electrostatic discharge protection are highlighted in the patent, emphasizing the importance of efficient and safe energy transfer for effective nerve stimulation within the body.

To know more about GlobalData’s detailed insights on Bioventus, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.